封面
市場調查報告書
商品編碼
1596812

醫用聚合物市場規模、佔有率和成長分析:按類型、醫療技術、應用和地區分類 - 產業預測,2024-2031 年

Medical Polymers Market Size, Share, Growth Analysis, By Type, By Medical Technology, By Application, By Region, By Region - Industry Forecast 2024-2031

出版日期: | 出版商: SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

2022年全球醫用聚合物市場規模將為199.3億美元,從2023年的215.3億美元成長到2031年的399.1億美元,並將從2023年的215.3億美元成長到2031年的399.1億美元。以複合年成長率成長2031 年為 8.02%)

全球醫用聚合物市場對於醫療設備、設備和包裝的生產至關重要,滿足安全有效的醫療保健應用所需的生物相容性、無菌性和耐用性等嚴格要求。這些先進材料具有多種功能,包括靈活性、強度和耐熱性,有助於開發創新的醫療解決方案,改善病患照護和治療結果。市場成長是由全球人口成長、慢性病盛行率上升以及醫療保健技術持續進步等因素所推動的。然而,製造商面臨嚴格的監管合規性、高開發成本以及需要持續材料創新以滿足不斷變化的醫療保健需求等挑戰。儘管存在這些障礙,但聚合物科學的進步,特別是創造具有改進性能的新材料,透過生物分解性的選擇來滿足永續性趨勢,以及對微創手術和個人化醫療的需求,透過應對以下問題,存在重大機會:醫用聚合物市場不僅為醫療製造提供必要的組件,而且還響應醫療保健行業的動態需求,並準備實現顯著成長和創新,同時克服複雜的法規環境和材料開拓挑戰。

目錄

介紹

  • 研究目的
  • 調查範圍
  • 定義

調查方法

  • 資訊採購
  • 二手資料和主要資料方法
  • 市場規模預測
  • 市場假設與限制

執行摘要

  • 全球市場展望
  • 供需趨勢分析
  • 按細分市場的機會分析

市場動態及展望

  • 市場概況
  • 市場規模
  • 市場動態
    • 促進因素和機遇
    • 抑制因素和挑戰
  • 波特分析與影響
    • 競爭公司之間的敵對關係
    • 替代品的威脅
    • 買方議價能力
    • 新進入者的威脅
    • 供應商的議價能力

主要市場考察

  • 關鍵成功因素
  • 競爭程度
  • 市場吸引力指數
  • 市場生態系統
  • 頂級投資
  • 監管環境
  • 價格分析
  • 價值鏈分析
  • 客戶和購買標準分析
  • 貿易分析
  • 案例研究分析
  • 專利分析

全球不同類型醫用聚合物市場規模(2019-2031)

  • 醫用塑膠
    • 聚丙烯(PP)
    • 聚氯乙烯(PVC)
    • 聚乙烯(PE)
    • 聚苯乙烯(PS)
    • 工程和高性能塑膠
    • 聚醚醚酮 (PEEK)
    • 尼龍/聚醯胺 (PA)
    • 多酚磺酸鹽(PPPSU)
    • 聚碸(PSU)
    • 聚甲基丙烯酸甲酯(PMMA)
    • 聚碳酸酯(PC)
    • 丙烯腈丁二烯苯乙烯 (ABS)
    • 其他
    • 其他
  • 醫用合成橡膠
    • 矽膠
    • 熱可塑性橡膠
    • 熱塑性聚氨酯(TPU)
    • 熱塑性硫化橡膠 (TPV)
    • 熱塑性合成橡膠彈性體(TPS)
    • 熱塑性共聚酯合成橡膠(TPC-ET)
  • 其他

依製造技術分類的全球醫用聚合物市場規模(2019-2031)

  • 擠壓管
  • 壓縮成型
  • 射出成型
  • 其他

全球醫用聚合物市場規模:依應用分類(2019-2031)

  • 醫療一次性產品
    • 手套
    • 注射器
    • 醫療袋
    • 其他
  • 醫療設備/設備
    • 醫用管
    • 導管
    • 藥物輸送
    • 其他
  • 義肢
    • 植入
    • 義肢
    • 其他
  • 診斷設備/工具
    • 牙科器械
    • 手術器械
    • 其他
  • 其他

全球醫用聚合物市場規模(按地區)(2019-2031)

  • 北美(按類型、技術、製造技術、應用)
    • 美國
    • 加拿大
  • 歐洲(按類型、技術、製造技術、應用)
    • 英國
    • 德國
    • 西班牙
    • 法國
    • 義大利
    • 其他歐洲國家地區
  • 亞太地區(按類型、技術、製造技術、應用)
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他亞太地區
  • 拉丁美洲(按類型、技術、製造技術、應用)
    • 巴西
    • 其他拉丁美洲地區
  • 中東/非洲(按類型、技術、製造技術、應用)
    • 海灣合作理事會國家
    • 南非
    • 其他中東/非洲

競爭資訊

  • 前5名企業對比
  • 主要企業市場定位(2023年)
  • 主要市場參與者所採取的策略
  • 近期市場趨勢
  • 公司市場佔有率分析(2023)

公司簡介

  • BASF SE
    • 公司簡介
    • 產品系列
    • 財務概覽
    • 最近的趨勢

排名前 20 名的公司也提供了類似的資訊。

  • SABIC
  • Covestro AG
  • Hoechst Celanese Corporation
  • Evonik Industries
  • Arkema
  • Solvay
  • Kuraray Co., Ltd.
  • Momentive Performance Materials Inc.
  • DuPont
  • Trinseo
  • DL Chemical (Kraton Corporation)
  • Total Plastics
  • Simona AG
  • DSM
  • Victrex plc group (Invibio)
  • Avient Corporation
  • RTP Company
  • Genstar Capital (Tekniplex)
  • Teknor Apex

結論

簡介目錄
Product Code: SQMIG15A2347

Global Medical Polymers Market size was valued at USD 19.93 billion in 2022 and is poised to grow from USD 21.53 billion in 2023 to USD 39.91 billion by 2031, growing at a CAGR of 8.02% in the forecast period (2024-2031)

The global medical polymers market is pivotal in the production of medical devices, equipment, and packaging, addressing the stringent requirements of biocompatibility, sterilizability, and durability essential for safe and effective healthcare applications. These advanced materials offer a diverse array of functionalities, including flexibility, strength, and heat resistance, thereby enabling the development of innovative medical solutions that enhance patient care and treatment outcomes. The market's growth is fueled by factors such as an increasing global population, a rising prevalence of chronic diseases, and ongoing technological advancements in healthcare. Nonetheless, manufacturers face challenges, including stringent regulatory compliance, high development costs, and the need for continuous material innovation to keep pace with evolving healthcare demands. Despite these obstacles, substantial opportunities exist, particularly in advancing polymer science to create novel materials with improved properties, responding to sustainability trends with biodegradable options, and catering to the demand for minimally invasive procedures and personalized medicine. The medical polymers market is set not only to provide essential components for medical manufacturing but also to address the dynamic needs of the healthcare industry, promoting substantial growth and innovation while navigating the complexities of regulatory environments and material development challenges.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Medical Polymers market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Medical Polymers Market Segmental Analysis

Global Medical Polymers Market is segmented by Type, Medical Technology, Application and region. Based on Type, the market can be segmented into Medical Plastics, Medical Elastomers and Others. Based on Medical Technology, the market can be segmented into Extrusion Tubing, Compression Molding, Injection Molding and Others. Based on Application, the market is segmented into Medical Disposables, Medical Instruments & Devices, Prosthetics, Diagnostic Instruments & Tools and Others. Based on region, the market is segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.

Driver of the Global Medical Polymers Market

The Global Medical Polymers market is significantly influenced by the rising demand for advanced medical devices and equipment. As of 2022, there has been a notable increase in the development and utilization of innovative medical technologies, including minimally invasive surgical instruments, wearable health devices, and diagnostic tools. These cutting-edge devices frequently depend on medical polymers for both their structural integrity and operational efficiency. This growing trend has consequently led to a heightened demand for polymers within the marketplace, highlighting their vital role in the ongoing advancement of healthcare solutions and the overall performance of modern medical applications.

Restraints in the Global Medical Polymers Market

The Global Medical Polymers market faces notable restraints primarily due to stringent regulatory requirements imposed by the medical industry. These regulations are essential to guarantee the safety and effectiveness of medical products, yet they present considerable challenges for manufacturers and suppliers. The process of complying with these rigorous standards involves obtaining necessary certifications and conducting thorough testing, which can be both time-intensive and financially burdensome. As a result, these factors can hinder the growth and competitiveness of market participants, making it difficult for them to navigate the complexities of regulatory compliance in the medical polymers sector.

Market Trends of the Global Medical Polymers Market

The Global Medical Polymers market is witnessing a transformative trend driven by the increasing focus on personalized medicine and the rising adoption of bioresorbable polymers. In 2022, bioresorbable polymers captured significant market attention, owing to their innovative properties that allow for gradual degradation and absorption by the body, mitigating the need for secondary surgical interventions. Their diverse applications across orthopedics, drug delivery systems, and wound care are enhancing patient outcomes and expediting recovery processes. This growing demand reflects a shift towards advanced, patient-centered healthcare solutions, positioning bioresorbable polymers as a key driver in the evolving landscape of medical polymers.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Driver & Opportunities
    • Restraints & Challenges
  • Porters Analysis & Impact
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Market Attractiveness Index
  • Market Ecosystem
  • Top Pocket Investment
  • Regulatory Landscape
  • Pricing Analysis
  • Value Chain Analysis
  • Customer and Buying Criteria Analysis
  • Trade Analysis
  • Case Study Analysis
  • Patent Analysis

Global Medical Polymers Market Size by Type (2019-2031)

  • Medical Plastics
    • Polypropylene (PP)
    • Polyvinyl Chloride (PVC)
    • Polyethylene (PE)
    • Polystyrene (PS)
    • Engineering & High-Performance Plastics
    • Polyether Ether Ketone (PEEK)
    • Nylon/Polyamide (PA)
    • Polyphenulsulfone (PPPSU)
    • Polysulfones (PSU)
    • Polymethyl Methacrylate (PMMA)
    • Polycarbonate (PC)
    • Acrylonitrile Butadiene Styrene (ABS)
    • Others
    • Others
  • Medical Elastomers
    • Silicone
    • Thermoplastic Elastomers
    • Thermoplastic Polyurethane (TPU)
    • Thermoplastic Vulcanizates (TPV)
    • Thermoplastic Styrenic Elastomers (TPS)
    • Thermoplastic Copolyester Elastomers (TPC-ET)
  • Others

Global Medical Polymers Market Size by Manufacturing Technology (2019-2031)

  • Extrusion Tubing
  • Compression Molding
  • Injection Molding
  • Others

Global Medical Polymers Market Size by Application (2019-2031)

  • Medical Disposables
    • Gloves
    • Syringes
    • Medical Bags
    • Others
  • Medical Instruments & Devices
    • Medical Tubes
    • Catheters
    • Drug Delivery
    • Others
  • Prosthetics
    • Implants
    • Limb Prosthesis
    • Others
  • Diagnostic Instruments & Tools
    • Dental Tools
    • Surgical Instruments
    • Others
  • Others

Global Medical Polymers Market Size by Region (2019-2031)

  • North America, (By Type, By Technology, Manufacturing Technology & By Application)
    • U.S.
    • Canada
  • Europe, (By Type, By Technology, Manufacturing Technology & By Application)
    • U.K.
    • Germany
    • Spain
    • France
    • Italy
    • Rest of Europe
  • Asia-Pacific, (By Type, By Technology, Manufacturing Technology & By Application)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia Pacific
  • Latin America, (By Type, By Technology, Manufacturing Technology & By Application)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa, (By Type, By Technology, Manufacturing Technology & By Application)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2023

Company Profiles

  • BASF SE
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Recent Developments

Similar information will be provided for top 20 players.

  • SABIC
  • Covestro AG
  • Hoechst Celanese Corporation
  • Evonik Industries
  • Arkema
  • Solvay
  • Kuraray Co., Ltd.
  • Momentive Performance Materials Inc.
  • DuPont
  • Trinseo
  • DL Chemical (Kraton Corporation)
  • Total Plastics
  • Simona AG
  • DSM
  • Victrex plc group (Invibio)
  • Avient Corporation
  • RTP Company
  • Genstar Capital (Tekniplex)
  • Teknor Apex

Conclusion